Showing results (1-10 of 612) with videos related to
Sort By:
Pageof 62
International Urology and Nephrology|September 9, 2015
Patient preferences for treating refractory overactive bladder in the UKHashim Hashim, Kathleen Beusterien, John F P Bridges, et al.Neurourology and Urodynamics|September 16, 2015
Use of best-worst scaling to assess patient perceptions of treatments for refractory overactive bladderKathleen Beusterien, Michael J Kennelly, John F P Bridges, et al.Current Medical Research and Opinion|September 26, 2017
Development of a stated-preference instrument to prioritize treatment goals in recent onset schizophreniaKathleen Beusterien, Elcie Chan, Pedro Such, et al.BMC Cancer|October 19, 2017
Societal preferences for adjuvant melanoma health states: UK and AustraliaMark R Middleton, Michael B Atkins, Kaitlan Amos, et al.Patient Preference and Adherence|October 18, 2023
Prioritizing Treatment Goals of People Diagnosed with Bipolar I Disorder in the US: Best-Worst Scaling ResultsJohn F P Bridges, Joseph F Goldberg, Heather M Fitzgerald, et al.Neurourology and Urodynamics|June 11, 2011
Constructing trials to show whether urodynamic studies are necessary in lower urinary tract dysfunctionJ L H Ruud Bosch, Linda Cardozo, Hashim Hashim, et al.Patient Preference and Adherence|May 24, 2019
Japanese patient preferences regarding intermediate to advanced hepatocellular carcinoma treatmentsTetsuhiro Chiba, Atsushi Hiraoka, Shigeru Mikami, et al.Current Opinion in Urology|May 19, 2009
Pharmacological treatment of overactive bladder: report from the International Consultation on IncontinenceKarl-Erik Andersson, Christopher R Chapple, Linda Cardozo, et al.Neurourology and Urodynamics|November 8, 2023
Which parameters, related to the female urethra and pelvic floor, determine therapy selection for recurrent female stress urinary incontinence: ICI-RS 2023?Jeremy Ockrim, Rohna Kearney, D Carolina Ochoa, et al.Pharmacoeconomics|February 8, 2013
Lean systems approaches to health technology assessment: a patient-focused alternative to cost-effectiveness analysisJohn F P BridgesPageof 62